Professor in Department of Breast Medical Oncology, MD Anderson Cancer Center
Dr.Banu Arun is Professor in the Department of Breast Medical Oncology, Co-Medical Director of the Clinical Cancer Genetics Program and Section Chief Breast Genetics, Prevention and Screening at the University of Texas MD Anderson Cancer Center. Her research focuses on identifying risk biomarkers for breast cancer and prevention, and characterizing risk factors in a cohort of high-risk women with hereditary gene mutations (BRCA and others) as well as assessing breast cancer biology in these patients. She has served as the Principal Investigator on several clinical trials evaluating agents such as letrozole, imatinib, gemcitabine, R115777 and PARP inhibitors for metastatic breast cancer (including BRCA positive,) and celecoxib, atorvastatin and dasatinib in short-term breast cancer prevention trials.
Given her national and international expertise she has served in several committees, including The American Society of Clinical Oncology (ASCO) Prevention committee and currently serves as the Co-Chair for the Southwest Oncology Group (SWOG) Prevention and Epidemiology Committee and member of the NCCN Breast Cancer Risk Reduction Guideline Committee, member of the ASCO BOLD task force, member of ASCO IDEA committee, and member of the National Cancer Institute (NCI) Cancer Prevention Steering Committee. She served as grant reviewer for Susan Komen and NCI P01 and reviewed for journal including JCO, Cancer, BMJ, Cancer Prevention and Epidemiology, among others. She has more than 200 peer reviewed publications and received research grants from the NCI, Susan Komen Foundation and CPRIT.
She was also featured in Forbes (December 2017) as one of the top 30 breast medical oncologists in the Nation.